Skip to Content
We welcome visitors to our care settings while they’re wearing masks. View our updated visitor guidelines.

Clinically Actionable Findings

Our GHI team has designed genetic research aimed at making improvements in the prevention, diagnosis and treatment of various diseases. Through our research, we may also:

  • Uncover data that is directly relevant to the health of individual participants, such as identifying high risk for some cancers or for cardiovascular disorders that are associated with sudden death.
  • Find results that point to genetic susceptibilities an individual might have to having severe toxic reactions to some drugs.

We expect that some of the results of our research will lead to clinically actionable findings—meaning a medical intervention, preventative approach or early detection is available. Furthermore, as research such as GHI continues in the medical genomics field, an increasing number of actionable genetic variants will be discovered.

There are many diseases with clinically actionable genes (and genetic variants) for which we currently screen. Below is a listing of some of the diseases that have clinically actionable genes. The American College of Medical Genetics and Genomics (ACMG) generated this list of disorders. Each disease below is hyperlinked to its “Genetics Home Reference” or other National Institutes of Health NIH informational gateway. Please note that these pages have useful information for GHI participants, but some of it can be considered technical.